메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

이혜원 (남부대학교, 남부대학교 보건경영대학원)

지도교수
박성주
발행연도
2018
저작권
남부대학교 논문은 저작권에 의해 보호받습니다.

이용수40

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
국문초록

수술실간호사의 정보제공프로그램이 말기 신질환자의 불안, 자기효능감 및 간호만족도에 미치는 효과
-동정맥루와 혈관성형술 대상자를 중심으로-

이 혜 원
지도교수: 박성주
간호학과
남부대학교 보건경영대학원

본 연구는 동정맥루 및 혈관성형술이 예정된 말기 신질환자를 대상으로 수술실간호사가 병실을 방문하여 수술 전·후 정보제공프로그램을 제공하고, 그 효과를 알아보기 위한 비동등성 대조군 전후설계를 이용한 유사 실험연구이다. 연구대상은 G시에 있는 S종합병원에서 말기 신질환으로 투석을 받고 있는 환자 중 동정맥루 또는 혈관성형술을 받기위해 입원한 환자를 대상으로 하였다. 정보제공프로그램을 적용하기 위하여 실험군 40명, 대조군 40명으로 총 80명을 편의표출 하였다. 연구기간은 2017년 6월 20일부터 10월 22일까지였으며, 자료 수집은 구조화된 설문지를 이용하고 개발된 정보제공프로그램을 사용하여 대상자를 방문하였다
측정도구로 불안은 Spielberger(1972)가 개발하고 김정택과 신동균(1978)이 번안한 상태-기질불안(State Trait Anxiety Inventory: STAI)도구와 Cline, Herman, Shaw 와 Morton(1992)이 표준화한 시각적상사척도(Visual Analogue Scale: VAS)를 사용하였다. 자기효능감 측정은 Sherer, Maddux, Jacobs 와 Rosers(1982)가 개발하고, 홍계영(1999)이 수정·보완한 자기효능감 도구를 사용하였다. 간호만족도는 류경(2014)이 사용한 도구를 본 연구자가 수정·보완하여 측정하였다.
본 연구에 수집된 자료는 SPSS/WIN 21.0 프로그램을 사용하여 분석하였다. 연구대상자의 인구사회학적 특성은 빈도분석을 하였다. 실험군과 대조군간의 일반적특성 및 종속변수에 대한 사전 동질성 검증은 χ²-test 와 t-test를 사용하였고, 수술실간호사의 정보제공프로그램을 제공 받은 실험군과 받지 않은 대조군간의 불안, 자기효능감 및 간호만족도 효과에 대한 차이는 t-test를 이용하였다.

연구의 결과는 다음과 같다.
제 1가설 ‘수술실간호사의 정보제공프로그램을 제공 받은 실험군과 받지 않은 대조군은 불안에 차이가 있을 것이다’는 실험군에서 기질불안(t=2.31, p< .024), 상태불안(t=10.18, p< .001)이 통계적으로 유의하게 낮게 나타나 제 1가설이 지지되었다.

제 2가설 ‘수술실간호사의 정보제공프로그램을 제공 받은 실험군과 받지 않은 대조군은 자기효능감에 차이가 있을 것이다’는 실험군의 자기효능감이 대조군보다 통계적으로 유의하게 높게 나타나(t=-4.59, p< .001) 제 2가설이 지지되었다.

제 3가설 ‘수술실간호사의 정보제공프로그램을 제공 받은 실험군과 받지 않은 대조군은 간호만족도에 차이가 있을 것이다’는 실험군의 간호만족도가 대조군보다 통계적으로 유의하게 높게 나타나(t=-7.18, p< .001) 제 3가설이 지지되었다.


본 연구 결과 수술실간호사의 정보제공프로그램이 말기 신질환자의 불안감소, 자기효능감 증진 및 간호만족도를 높이기 위한 효과가 검증되어 동정맥루와 혈관성형술이 예정된 환자를 위한 교육 자료로 활용할 수 있을 것으로 사료된다.



주요어 : 정보제공 프로그램, 말기 신질환자, 불안, 자기효능감, 간호만족도

목차

목 차
표목차·············································································· ⅲ
그림목차··········································································· ⅳ
국문초록··········································································· ⅴ
Ⅰ. 서론··································································· 1
1. 연구의 필요성······················································· 1
2. 연구목적······························································ 4
3. 연구가설······························································ 4
4. 용어정의······························································ 5
Ⅱ. 문헌고찰······························································ 8
1. 정보제공프로그램···················································· 8
2. 말기 신질환자······················································· 10
3. 불안·································································· 13
4. 자기효능감·························································· 15
5. 간호만족도 ···················································‥‥· 17
Ⅲ. 연구방법····························································· 20
1. 연구설계····························································· 20
2. 연구대상··························································· 21
3. 연구도구····························································· 22
4. 연구진행절차························································ 24
5. 자료분석····························································· 31
6. 연구자의 윤리적 고려············································ 32
Ⅳ. 연구결과···························································· 33
1. 대상자의 일반적 특성과 정규분포 및 동질성 검증·········· 33
가. 대상자의 일반적 특성······················································· 33
나. 자료의 정규분포 검증······················································ 36
다. 실험군과 대조군의 동질성 검증·········································· 36
라. 실험군과 대조군의 종속변수에 대한 동질성 검증······················· 36
2. 가설검증···························································· 38
Ⅴ. 논의···································································· 42
Ⅵ. 결론······································································ 50
참고문헌········································································· 53
Abstract···································································· 63
부록·········································································· 66
설문지········································································· 68

최근 본 자료

전체보기

댓글(0)

0